Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant Start Printed Page 29660applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel, Innovative Therapies and Clinical Studies for Screenable Disorders.
Date: June 9, 2006.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn/Marriott, 550 Army Navy Drive, Arlington, VA 22202.
Contact Person: Norman Chang, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health and Human Development, NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892, (301) 496-1485, firstname.lastname@example.org.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS)Start Signature
Dated: May 17, 2006.
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-4789 Filed 5-22-06; 8:45 am]
BILLING CODE 4140-01-M